Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Boruta

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Gynecologic Oncology|January 28, 2014
Transitional cell carcinoma of the ovary: a case-control studyStephanie H Guseh, J Alejandro Rauh-Hain, Rosemary H Tambouret, et al.
Gynecologic Oncology|August 3, 2013
Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysisJ Alejandro Rauh-Hain, Elisabeth J Diver, Joel T Clemmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2025
Surgical and blood-based minimal residual disease in patients with ovarian cancer after frontline therapy: Clinical outcomes and translational opportunitiesAnne Knisely, Yibo Dai, Graham L Barlow, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Gynecologic Oncology|January 28, 2014
Transitional cell carcinoma of the ovary: a case-control studyStephanie H Guseh, J Alejandro Rauh-Hain, Rosemary H Tambouret, et al.
Gynecologic Oncology|August 3, 2013
Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysisJ Alejandro Rauh-Hain, Elisabeth J Diver, Joel T Clemmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2025
Surgical and blood-based minimal residual disease in patients with ovarian cancer after frontline therapy: Clinical outcomes and translational opportunitiesAnne Knisely, Yibo Dai, Graham L Barlow, et al.
Pageof 6